CP-810123

CC1=CC=C2OC(=NC2=N1)N3CCN4CCC3CC4

InChIKey=BSNKYWSMUAGMDO-UHFFFAOYSA-N

InChI=1S/C14H18N4O/c1-10-2-3-12-13(15-10)16-14(19-12)18-9-8-17-6-4-11(18)5-7-17/h2-3,11H,4-9H2,1H3

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

PubMed

Title	Date	PubMed
Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition models.	2010-02-11	20043678

Substance Class	Chemical Created by `admin` on `Mon Mar 31 21:56:02 GMT 2025` Edited by `admin` on `Mon Mar 31 21:56:02 GMT 2025`
Record UNII	E6G4550EC4
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

CP-810123

Common Name

English

1,4-DIAZABICYCLO(3.2.2)NONANE, 4-(5-METHYLOXAZOLO(4,5-B)PYRIDIN-2-YL)-

Preferred Name

English

Code System Code Type Description

CAS

439608-12-5

Created by admin on Mon Mar 31 21:56:02 GMT 2025 , Edited by admin on Mon Mar 31 21:56:02 GMT 2025

PRIMARY

FDA UNII

E6G4550EC4

Created by admin on Mon Mar 31 21:56:02 GMT 2025 , Edited by admin on Mon Mar 31 21:56:02 GMT 2025

PRIMARY

PUBCHEM

11184481

Created by admin on Mon Mar 31 21:56:02 GMT 2025 , Edited by admin on Mon Mar 31 21:56:02 GMT 2025

PRIMARY

Related Record Type Details


					P4J1I8C6CX

TARGET -> AGONIST

Comments:

(.ALPHA.7 NACHR) IN VITRO DATA KI = 13.5 NM

Amount:

Related Record Type Details


					E6G4550EC4

ACTIVE MOIETY